G01N 2333/90283
Acting on superoxide radicals as acceptor
Official title: acting on superoxide radicals as acceptor (1.15)
G01N2333/90283 (Acting on superoxide radicals as acceptor) appears on 29 US grants and 73 published applications in this corpus.
Search patents in G01N- Granted patents
- 29
- Published applications
- 73
- Assignees
- 42
- Inventors
- 125
- Latest grant
- 5 Aug 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2003 | 0 | 1 |
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 2 |
| 2007 | 0 | 4 |
| 2008 | 1 | 6 |
| 2009 | 0 | 5 |
| 2010 | 1 | 2 |
| 2011 | 4 | 4 |
| 2012 | 0 | 2 |
| 2013 | 2 | 3 |
| 2014 | 3 | 9 |
| 2015 | 0 | 1 |
| 2016 | 4 | 6 |
| 2017 | 3 | 4 |
| 2018 | 1 | 2 |
| 2019 | 2 | 5 |
| 2020 | 1 | 1 |
| 2021 | 0 | 0 |
| 2022 | 3 | 4 |
| 2023 | 0 | 4 |
| 2024 | 2 | 2 |
| 2025 | 2 | 3 |
| 2026 | 0 | 2 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Anti superoxide dismutase 1 (SOD1) antibodies and use thereof5 Aug 2025US 12,378,324 B2B. G. Negev Technologies and Applications Ltd., At Ben-Gurion University
- Assays and methods for targeted treatment of hydrosalpinx29 Apr 2025US 12,287,341 B2The Government of the United States, as represented by the Secretary of the Army
- Biomarkers useful in the treatment of subjects having diseases of the eye3 Sep 2024US 12,078,641 B2The Johns Hopkins University
- Methods for detection, staging, and surveillance of colorectal adenomas and carcinomas19 Mar 2024US 11,933,785 B2Wisconsin Alumni Research Foundation
- Biological toxicity test method for evaluating the ecological safety of advanced oxidation processes29 Nov 2022US 11,513,109 B2Nanjing University
- Administration of yunnan baiyao or xingnaojing in patients with moderate-to-sever traumatic brain injury and craniotomy30 Jul 2026US 2026/0216274 A1Lotus Biotech.com LLC
- Biomarkers for Long COVID7 May 2026US 2026/0126444 A1Szegedi TudomáNyegyetem
- Anti-sod1 nanobodies25 Dec 2025US 2025/0388697 A1University of Massachusetts
- Test method for physical frailty, test reagent for physical frailty, method for screening therapeutic candidate substance for physical frailty, test melthod for mental frailty, test reagent for mental frailty, and method for screening therapeutic cnadidate substance for mental frailty21 Aug 2025US 2025/0263772 A1Bioradical Research Institute Corp.
- Analytical method and therapeutical agent for use in combination with l-asparaginase in tumour therapy19 Jun 2025US 2025/0195628 A1Medizinische Hochschule Hannover
Most cited
By later US patents
- ALS-specific peptide composition16US 7,439,324 B2Amorfix Life Sciences Ltd. · 2008
- Methods and compositions to treat and detect misfolded-SOD1 mediated diseases11US 8,778,885 B2Amorfix Life Sciences Ltd. · 2014
- Methods and compositions to treat and detect misfolded-SOD1 mediated diseases10US 7,977,314 B2Amorfix Life Sciences Ltd. · 2011
- Methods and compositions to treat and detect misfolded-SOD1 mediated diseases9US 9,637,552 B2ProMIS Neurosciences Inc. · 2017
- ALS-specific peptide composition6US 7,763,710 B2Amorfix Life Sciences Ltd. · 2010